Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

George L. Mutter, M.D.

Concepts

This page shows the publications George Mutter has written about Female.
Connection Strength

0.343
  1. Howitt BE, Monte NM, Elvin J, Mutter GL. Dyssynchronous secretory endometrial glands often show sporadically acquired progesterone nonresponsiveness. Int J Gynecol Pathol. 2015 May; 34(3):239-44.
    View in: PubMed
    Score: 0.011
  2. Yang EJ, Mutter GL. Biomarker resolution of uterine smooth muscle tumor necrosis as benign vs malignant. Mod Pathol. 2015 Jun; 28(6):830-5.
    View in: PubMed
    Score: 0.011
  3. Mutter GL, Monte NM, Neuberg D, Ferenczy A, Eng C. Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues. Cancer Res. 2014 May 15; 74(10):2796-802.
    View in: PubMed
    Score: 0.010
  4. Parra-Herran CE, Monte NM, Mutter GL. Endometrial intraepithelial neoplasia with secretory differentiation: diagnostic features and underlying mechanisms. Mod Pathol. 2013 Jun; 26(6):868-73.
    View in: PubMed
    Score: 0.010
  5. Quick CM, Laury AR, Monte NM, Mutter GL. Utility of PAX2 as a marker for diagnosis of endometrial intraepithelial neoplasia. Am J Clin Pathol. 2012 Nov; 138(5):678-84.
    View in: PubMed
    Score: 0.009
  6. Semere LG, Ko E, Johnson NR, Vitonis AF, Phang LJ, Cramer DW, Mutter GL. Endometrial intraepithelial neoplasia: clinical correlates and outcomes. Obstet Gynecol. 2011 Jul; 118(1):21-8.
    View in: PubMed
    Score: 0.009
  7. Jarboe EA, Mutter GL. Endometrial intraepithelial neoplasia. Semin Diagn Pathol. 2010 Nov; 27(4):215-25.
    View in: PubMed
    Score: 0.008
  8. Monte NM, Webster KA, Neuberg D, Dressler GR, Mutter GL. Joint loss of PAX2 and PTEN expression in endometrial precancers and cancer. Cancer Res. 2010 Aug 01; 70(15):6225-32.
    View in: PubMed
    Score: 0.008
  9. Lin MC, Burkholder KA, Viswanathan AN, Neuberg D, Mutter GL. Involution of latent endometrial precancers by hormonal and nonhormonal mechanisms. Cancer. 2009 May 15; 115(10):2111-8.
    View in: PubMed
    Score: 0.007
  10. Ioffe OB, Zaino RJ, Mutter GL. Endometrial changes from short-term therapy with CDB-4124, a selective progesterone receptor modulator. Mod Pathol. 2009 Mar; 22(3):450-9.
    View in: PubMed
    Score: 0.007
  11. Lin MC, Lomo L, Baak JP, Eng C, Ince TA, Crum CP, Mutter GL. Squamous morules are functionally inert elements of premalignant endometrial neoplasia. Mod Pathol. 2009 Feb; 22(2):167-74.
    View in: PubMed
    Score: 0.007
  12. Carlson JW, Mutter GL. Endometrial intraepithelial neoplasia is associated with polyps and frequently has metaplastic change. Histopathology. 2008 Sep; 53(3):325-32.
    View in: PubMed
    Score: 0.007
  13. Lomo L, Nucci MR, Lee KR, Lin MC, Hirsch MS, Crum CP, Mutter GL. Histologic and immunohistochemical decision-making in endometrial adenocarcinoma. Mod Pathol. 2008 Aug; 21(8):937-42.
    View in: PubMed
    Score: 0.007
  14. Mutter GL, Kauderer J, Baak JP, Alberts D. Biopsy histomorphometry predicts uterine myoinvasion by endometrial carcinoma: a Gynecologic Oncology Group study. Hum Pathol. 2008 Jun; 39(6):866-74.
    View in: PubMed
    Score: 0.007
  15. Mutter GL, Bergeron C, Deligdisch L, Ferenczy A, Glant M, Merino M, Williams AR, Blithe DL. The spectrum of endometrial pathology induced by progesterone receptor modulators. Mod Pathol. 2008 May; 21(5):591-8.
    View in: PubMed
    Score: 0.007
  16. Mutter GL, Zaino RJ, Baak JP, Bentley RC, Robboy SJ. Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia. Int J Gynecol Pathol. 2007 Apr; 26(2):103-14.
    View in: PubMed
    Score: 0.006
  17. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol. 2006 Oct 10; 24(29):4783-91.
    View in: PubMed
    Score: 0.006
  18. Ørbo A, Rise CE, Mutter GL. Regression of latent endometrial precancers by progestin infiltrated intrauterine device. Cancer Res. 2006 Jun 01; 66(11):5613-7.
    View in: PubMed
    Score: 0.006
  19. Hecht JL, Ince TA, Baak JP, Baker HE, Ogden MW, Mutter GL. Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis. Mod Pathol. 2005 Mar; 18(3):324-30.
    View in: PubMed
    Score: 0.006
  20. Baak JP, Mutter GL. EIN and WHO94. J Clin Pathol. 2005 Jan; 58(1):1-6.
    View in: PubMed
    Score: 0.005
  21. Mutter GL, Zahrieh D, Liu C, Neuberg D, Finkelstein D, Baker HE, Warrington JA. Comparison of frozen and RNALater solid tissue storage methods for use in RNA expression microarrays. BMC Genomics. 2004 Nov 10; 5:88.
    View in: PubMed
    Score: 0.005
  22. Zheng W, Baker HE, Mutter GL. Involution of PTEN-null endometrial glands with progestin therapy. Gynecol Oncol. 2004 Mar; 92(3):1008-13.
    View in: PubMed
    Score: 0.005
  23. Crum CP, Hornstein MD, Nucci MR, Mutter GL. Hertig and beyond: a systematic and practical approach to the endometrial biopsy. Adv Anat Pathol. 2003 Nov; 10(6):301-18.
    View in: PubMed
    Score: 0.005
  24. Tadesse MG, Ibrahim JG, Mutter GL. Identification of differentially expressed genes in high-density oligonucleotide arrays accounting for the quantification limits of the technology. Biometrics. 2003 Sep; 59(3):542-54.
    View in: PubMed
    Score: 0.005
  25. Mutter GL. Diagnosis of premalignant endometrial disease. J Clin Pathol. 2002 May; 55(5):326-31.
    View in: PubMed
    Score: 0.005
  26. Mutter GL, Baak JP, Fitzgerald JT, Gray R, Neuberg D, Kust GA, Gentleman R, Gullans SR, Wei LJ, Wilcox M. Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation. Gynecol Oncol. 2001 Nov; 83(2):177-85.
    View in: PubMed
    Score: 0.004
  27. Johnson EB, Muto MG, Yanushpolsky EH, Mutter GL. Phytoestrogen supplementation and endometrial cancer. Obstet Gynecol. 2001 Nov; 98(5 Pt 2):947-50.
    View in: PubMed
    Score: 0.004
  28. Mutter GL, Ince TA, Baak JP, Kust GA, Zhou XP, Eng C. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res. 2001 Jun 01; 61(11):4311-4.
    View in: PubMed
    Score: 0.004
  29. Mutter GL. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol. 2000 Oct; 19(4):301-9.
    View in: PubMed
    Score: 0.004
  30. Faquin WC, Fitzgerald JT, Boynton KA, Mutter GL. Intratumoral genetic heterogeneity and progression of endometrioid type endometrial adenocarcinomas. Gynecol Oncol. 2000 Aug; 78(2):152-7.
    View in: PubMed
    Score: 0.004
  31. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Baak JP, Lees JA, Weng LP, Eng C. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst. 2000 Jun 07; 92(11):924-30.
    View in: PubMed
    Score: 0.004
  32. Mutter GL, Lin MC, Fitzgerald JT, Kum JB, Eng C. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocrinol Metab. 2000 Jun; 85(6):2334-8.
    View in: PubMed
    Score: 0.004
  33. Faquin WC, Fitzgerald JT, Lin MC, Boynton KA, Muto MG, Mutter GL. Sporadic microsatellite instability is specific to neoplastic and preneoplastic endometrial tissues. Am J Clin Pathol. 2000 Apr; 113(4):576-82.
    View in: PubMed
    Score: 0.004
  34. Mutter GL. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol. 2000 Mar; 76(3):287-90.
    View in: PubMed
    Score: 0.004
  35. Mutter GL, Baak JP, Crum CP, Richart RM, Ferenczy A, Faquin WC. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol. 2000 Mar; 190(4):462-9.
    View in: PubMed
    Score: 0.004
  36. Nucci MR, Prasad CJ, Crum CP, Mutter GL. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol. 1999 Dec; 12(12):1137-42.
    View in: PubMed
    Score: 0.004
  37. Mutter GL, Wada H, Faquin WC, Enomoto T. K-ras mutations appear in the premalignant phase of both microsatellite stable and unstable endometrial carcinogenesis. Mol Pathol. 1999 Oct; 52(5):257-62.
    View in: PubMed
    Score: 0.004
  38. Ditzel HM, Strickland KC, Meserve EE, Stover E, Konstantinopoulos PA, Matulonis UA, Muto MG, Liu JF, Feltmate C, Horowitz N, Berkowitz RS, Gupta M, Hecht JL, Lin DI, Jochumsen KM, Welch WR, Hirsch MS, Quade BJ, Lee KR, Crum CP, Mutter GL, Nucci MR, Howitt BE. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240.
    View in: PubMed
    Score: 0.004
  39. Rabban JT, Gilks CB, Malpica A, Matias-Guiu X, Mittal K, Mutter GL, Oliva E, Parkash V, Ronnett BM, Staats P, Stewart CJR, McCluggage WG. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists. Int J Gynecol Pathol. 2019 Jan; 38 Suppl 1:S25-S39.
    View in: PubMed
    Score: 0.004
  40. Busch EL, Crous-Bou M, Prescott J, Downing MJ, Rosner BA, Mutter GL, De Vivo I. Adiponectin, Leptin, and Insulin-Pathway Receptors as Endometrial Cancer Subtyping Markers. Horm Cancer. 2018 02; 9(1):33-39.
    View in: PubMed
    Score: 0.003
  41. Mutter GL. Role of imprinting in abnormal human development. Mutat Res. 1997 Dec 12; 396(1-2):141-7.
    View in: PubMed
    Score: 0.003
  42. Longacre TA, Broaddus R, Chuang LT, Cohen MB, Jarboe EA, Mutter GL, Otis CN, Zaino RJ. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Endometrium. Arch Pathol Lab Med. 2017 11; 141(11):1508-1512.
    View in: PubMed
    Score: 0.003
  43. Stewart CL, Pedersen R, Rotwein P, Bestor T, Rastan S, Hastie N, Nichols R, Mutter G. NIEHS/EPA Workshops. Genomic imprinting. Reprod Toxicol. 1997 Mar-Jun; 11(2-3):309-16.
    View in: PubMed
    Score: 0.003
  44. Crum CP, McLachlin CM, Tate JE, Mutter GL. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol. 1997 Feb; 9(1):63-9.
    View in: PubMed
    Score: 0.003
  45. Busch EL, Crous-Bou M, Prescott J, Chen MM, Downing MJ, Rosner BA, Mutter GL, De Vivo I. Endometrial Cancer Risk Factors, Hormone Receptors, and Mortality Prediction. Cancer Epidemiol Biomarkers Prev. 2017 05; 26(5):727-735.
    View in: PubMed
    Score: 0.003
  46. Saglam A, Usubütün A, Dolgun A, Mutter GL, Salman MC, Kurtulan O, Akyol A, Özkan EA, Baykara S, Bülbül D, Calay Z, Eren F, Gümürdülü D, Haberal N, Ilvan S, Karaveli S, Koyuncuoglu M, Müezzinoglu B, Müftüoglu KH, Özen Ö, Özdemir N, Pestereli E, Ulukus Ç, Zekioglu O. Diagnostic and Treatment Reproducibility of Cervical Intraepithelial Neoplasia / Squamous Intraepithelial Lesion and Factors Affecting the Diagnosis. Turk Patoloji Derg. 2017; 1(1):177-191.
    View in: PubMed
    Score: 0.003
  47. Sinnock KL, Perez-Atayde AR, Boynton KA, Mutter GL. Clonal analysis of sacrococcygeal "teratomas". Pediatr Pathol Lab Med. 1996 Nov-Dec; 16(6):865-75.
    View in: PubMed
    Score: 0.003
  48. Mutter GL, Boynton KA, Faquin WC, Ruiz RE, Jovanovic AS. Allelotype mapping of unstable microsatellites establishes direct lineage continuity between endometrial precancers and cancer. Cancer Res. 1996 Oct 01; 56(19):4483-6.
    View in: PubMed
    Score: 0.003
  49. Jovanovic AS, Boynton KA, Mutter GL. Uteri of women with endometrial carcinoma contain a histopathological spectrum of monoclonal putative precancers, some with microsatellite instability. Cancer Res. 1996 Apr 15; 56(8):1917-21.
    View in: PubMed
    Score: 0.003
  50. Mutter GL, Boynton KA. X chromosome inactivation in the normal female genital tract: implications for identification of neoplasia. Cancer Res. 1995 Nov 01; 55(21):5080-4.
    View in: PubMed
    Score: 0.003
  51. Mutter GL, Boynton KA. PCR bias in amplification of androgen receptor alleles, a trinucleotide repeat marker used in clonality studies. Nucleic Acids Res. 1995 Apr 25; 23(8):1411-8.
    View in: PubMed
    Score: 0.003
  52. Mutter GL, Chaponot ML, Fletcher JA. A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol. 1995 Feb; 146(2):501-8.
    View in: PubMed
    Score: 0.003
  53. Nagymanyoki Z, Mutter GL, Hornick JL, Cibas ES. ARID1A is a useful marker of malignancy in peritoneal washings for endometrial carcinoma. Cancer Cytopathol. 2015 Apr; 123(4):253-7.
    View in: PubMed
    Score: 0.003
  54. Roberts DJ, Mutter GL. Advances in the molecular biology of gestational trophoblastic disease. J Reprod Med. 1994 Mar; 39(3):201-8.
    View in: PubMed
    Score: 0.003
  55. Mutter GL, Stewart CL, Chaponot ML, Pomponio RJ. Oppositely imprinted genes H19 and insulin-like growth factor 2 are coexpressed in human androgenetic trophoblast. Am J Hum Genet. 1993 Nov; 53(5):1096-102.
    View in: PubMed
    Score: 0.003
  56. Mutter GL, Pomponio RJ, Berkowitz RS, Genest DR. Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol. 1993 May; 168(5):1547-51.
    View in: PubMed
    Score: 0.002
  57. Trimble CL, Method M, Leitao M, Lu K, Ioffe O, Hampton M, Higgins R, Zaino R, Mutter GL. Management of endometrial precancers. Obstet Gynecol. 2012 Nov; 120(5):1160-75.
    View in: PubMed
    Score: 0.002
  58. Hornstein MD, Cohen JN, Thomas PP, Gleason RE, Friedman AJ, Mutter GL. The effect of consecutive day inseminations on semen characteristics in an intrauterine insemination program. Fertil Steril. 1992 Aug; 58(2):433-5.
    View in: PubMed
    Score: 0.002
  59. Usubutun A, Mutter GL, Saglam A, Dolgun A, Ozkan EA, Ince T, Akyol A, Bulbul HD, Calay Z, Eren F, Gumurdulu D, Haberal AN, Ilvan S, Karaveli S, Koyuncuoglu M, Muezzinoglu B, Muftuoglu KH, Ozdemir N, Ozen O, Baykara S, Pestereli E, Ulukus EC, Zekioglu O. Reproducibility of endometrial intraepithelial neoplasia diagnosis is good, but influenced by the diagnostic style of pathologists. Mod Pathol. 2012 Jun; 25(6):877-84.
    View in: PubMed
    Score: 0.002
  60. Mutter GL, Pomponio RJ. Molecular diagnosis of sex chromosome aneuploidy using quantitative PCR. Nucleic Acids Res. 1991 Aug 11; 19(15):4203-7.
    View in: PubMed
    Score: 0.002
  61. Chen EY, Mehra K, Mehrad M, Ning G, Miron A, Mutter GL, Monte N, Quade BJ, McKeon FD, Yassin Y, Xian W, Crum CP. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube. J Pathol. 2010 Sep; 222(1):110-6.
    View in: PubMed
    Score: 0.002
  62. Huang EC, Mutter GL, Crum CP, Nucci MR. Clinical outcome in diagnostically ambiguous foci of 'gland crowding' in the endometrium. Mod Pathol. 2010 Nov; 23(11):1486-91.
    View in: PubMed
    Score: 0.002
  63. Roh MH, Yassin Y, Miron A, Mehra KK, Mehrad M, Monte NM, Mutter GL, Nucci MR, Ning G, Mckeon FD, Hirsch MS, Wa X, Crum CP. High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression. Mod Pathol. 2010 Oct; 23(10):1316-24.
    View in: PubMed
    Score: 0.002
  64. Jarboe EA, Miron A, Carlson JW, Hirsch MS, Kindelberger D, Mutter GL, Crum CP, Nucci MR. Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance. Int J Gynecol Pathol. 2009 Jul; 28(4):308-15.
    View in: PubMed
    Score: 0.002
  65. Jarboe EA, Pizer ES, Miron A, Monte N, Mutter GL, Crum CP. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod Pathol. 2009 Mar; 22(3):345-50.
    View in: PubMed
    Score: 0.002
  66. Lacey JV, Mutter GL, Nucci MR, Ronnett BM, Ioffe OB, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer. 2008 Oct 15; 113(8):2073-81.
    View in: PubMed
    Score: 0.002
  67. Lacey JV, Mutter GL, Ronnett BM, Ioffe OB, Duggan MA, Rush BB, Glass AG, Richesson DA, Chatterjee N, Langholz B, Sherman ME. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res. 2008 Jul 15; 68(14):6014-20.
    View in: PubMed
    Score: 0.002
  68. Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, Platzer P, Eng C. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med. 2007 Dec 20; 357(25):2543-51.
    View in: PubMed
    Score: 0.002
  69. Mutter GL. Teratoma genetics and stem cells: a review. Obstet Gynecol Surv. 1987 Nov; 42(11):661-70.
    View in: PubMed
    Score: 0.002
  70. Mutter GL, Wolgemuth DJ. Distinct developmental patterns of c-mos protooncogene expression in female and male mouse germ cells. Proc Natl Acad Sci U S A. 1987 Aug; 84(15):5301-5.
    View in: PubMed
    Score: 0.002
  71. Dee GJ, Austin JH, Mutter GL. Bleomycin-associated pulmonary fibrosis: rapidly fatal progression without chest radiotherapy. J Surg Oncol. 1987 Jun; 35(2):135-8.
    View in: PubMed
    Score: 0.002
  72. Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA. 2007 May 16; 297(19):2103-11.
    View in: PubMed
    Score: 0.002
  73. Mutter GL, Stacey A, Wolgemuth DJ. Differential expression in murine somatic and germinal tissues of transcripts homologous to an abundant embryonal-carcinoma-cell mRNA. Differentiation. 1987; 34(2):126-30.
    View in: PubMed
    Score: 0.002
  74. Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T, Eng C. Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet. 2006 Jun; 78(6):961-72.
    View in: PubMed
    Score: 0.001
  75. Baak JP, Mutter GL, Robboy S, van Diest PJ, Uyterlinde AM, Orbo A, Palazzo J, Fiane B, Løvslett K, Burger C, Voorhorst F, Verheijen RH. The molecular genetics and morphometry-based endometrial intraepithelial neoplasia classification system predicts disease progression in endometrial hyperplasia more accurately than the 1994 World Health Organization classification system. Cancer. 2005 Jun 01; 103(11):2304-12.
    View in: PubMed
    Score: 0.001
  76. Baak JP, Van Diermen B, Steinbakk A, Janssen E, Skaland I, Mutter GL, Fiane B, Løvslett K. Lack of PTEN expression in endometrial intraepithelial neoplasia is correlated with cancer progression. Hum Pathol. 2005 May; 36(5):555-61.
    View in: PubMed
    Score: 0.001
  77. Fukino K, Shen L, Matsumoto S, Morrison CD, Mutter GL, Eng C. Combined total genome loss of heterozygosity scan of breast cancer stroma and epithelium reveals multiplicity of stromal targets. Cancer Res. 2004 Oct 15; 64(20):7231-6.
    View in: PubMed
    Score: 0.001
  78. Quade BJ, Wang TY, Sornberger K, Dal Cin P, Mutter GL, Morton CC. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling. Genes Chromosomes Cancer. 2004 Jun; 40(2):97-108.
    View in: PubMed
    Score: 0.001
  79. Styer AK, Cekleniak NA, Legedza A, Mutter GL, Hornstein MD. Factors associated with disposition of cryopreserved reproductive tissue. Fertil Steril. 2003 Sep; 80(3):584-9.
    View in: PubMed
    Score: 0.001
  80. Nucci MR, Castrillon DH, Bai H, Quade BJ, Ince TA, Genest DR, Lee KR, Mutter GL, Crum CP. Biomarkers in diagnostic obstetric and gynecologic pathology: a review. Adv Anat Pathol. 2003 Mar; 10(2):55-68.
    View in: PubMed
    Score: 0.001
  81. Wright TC, Holinka CF, Ferenczy A, Gatsonis CA, Mutter GL, Nicosia S, Richart RM. Estradiol-induced hyperplasia in endometrial biopsies from women on hormone replacement therapy. Am J Surg Pathol. 2002 Oct; 26(10):1269-75.
    View in: PubMed
    Score: 0.001
  82. Ince TA, Cviko AP, Quade BJ, Yang A, McKeon FD, Mutter GL, Crum CP. p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol. 2002 Oct; 161(4):1111-7.
    View in: PubMed
    Score: 0.001
  83. Hsiao LL, Dangond F, Yoshida T, Hong R, Jensen RV, Misra J, Dillon W, Lee KF, Clark KE, Haverty P, Weng Z, Mutter GL, Frosch MP, MacDonald ME, Milford EL, Crum CP, Bueno R, Pratt RE, Mahadevappa M, Warrington JA, Stephanopoulos G, Stephanopoulos G, Gullans SR. A compendium of gene expression in normal human tissues. Physiol Genomics. 2001 Dec 21; 7(2):97-104.
    View in: PubMed
    Score: 0.001
  84. O'Connell JT, Mutter GL, Cviko A, Nucci M, Quade BJ, Kozakewich HP, Neffen E, Sun D, Yang A, McKeon FD, Crum CP. Identification of a basal/reserve cell immunophenotype in benign and neoplastic endometrium: a study with the p53 homologue p63. Gynecol Oncol. 2001 Jan; 80(1):30-6.
    View in: PubMed
    Score: 0.001
  85. Biswas DK, Cruz A, Pettit N, Mutter GL, Pardee AB. A therapeutic target for hormone-independent estrogen receptor-positive breast cancers. Mol Med. 2001 Jan; 7(1):59-67.
    View in: PubMed
    Score: 0.001
  86. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB, Herman JG. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol. 1999 Nov; 155(5):1767-72.
    View in: PubMed
    Score: 0.001
  87. Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, Komminoth P, Lees JA, Mulligan LM, Mutter GL, Eng C. Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol. 1999 Oct; 155(4):1253-60.
    View in: PubMed
    Score: 0.001
  88. Pinto AP, Lin MC, Mutter GL, Sun D, Villa LL, Crum CP. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas. Am J Pathol. 1999 Apr; 154(4):1009-15.
    View in: PubMed
    Score: 0.001
  89. Lin MC, Mutter GL, Trivijisilp P, Boynton KA, Sun D, Crum CP. Patterns of allelic loss (LOH) in vulvar squamous carcinomas and adjacent noninvasive epithelia. Am J Pathol. 1998 May; 152(5):1313-8.
    View in: PubMed
    Score: 0.001
  90. Quade BJ, McLachlin CM, Soto-Wright V, Zuckerman J, Mutter GL, Morton CC. Disseminated peritoneal leiomyomatosis. Clonality analysis by X chromosome inactivation and cytogenetics of a clinically benign smooth muscle proliferation. Am J Pathol. 1997 Jun; 150(6):2153-66.
    View in: PubMed
    Score: 0.001
  91. Tate JE, Mutter GL, Boynton KA, Crum CP. Monoclonal origin of vulvar intraepithelial neoplasia and some vulvar hyperplasias. Am J Pathol. 1997 Jan; 150(1):315-22.
    View in: PubMed
    Score: 0.001
  92. McLachlin CM, Mutter GL, Crum CP. Multinucleated atypia of the vulva. Report of a distinct entity not associated with human papillomavirus. Am J Surg Pathol. 1994 Dec; 18(12):1233-9.
    View in: PubMed
    Score: 0.001
  93. Zitz JC, McLachlin CM, Tate JE, Mutter GL, Crum CP. Restriction fragment length polymorphism analysis of isotype-labeled polymerase chain reaction-amplified human papillomavirus DNA combines sensitivity with built-in contaminant detection. Mod Pathol. 1994 Apr; 7(3):407-11.
    View in: PubMed
    Score: 0.001
  94. Tate JE, Mutter GL, Prasad CJ, Berkowitz R, Goodman H, Crum CP. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Gynecol Oncol. 1994 Apr; 53(1):78-83.
    View in: PubMed
    Score: 0.001
  95. Iwaoki Y, Matsuda H, Mutter GL, Watrin F, Wolgemuth DJ. Differential expression of the proto-oncogenes c-abl and c-mos in developing mouse germ cells. Exp Cell Res. 1993 Jun; 206(2):212-9.
    View in: PubMed
    Score: 0.001
  96. Robertson NG, Pomponio RJ, Mutter GL, Morton CC. Testis-specific expression of the human MYCL2 gene. Nucleic Acids Res. 1991 Jun 11; 19(11):3129-37.
    View in: PubMed
    Score: 0.001
  97. Balling R, Mutter G, Gruss P, Kessel M. Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1.1 in transgenic mice. Cell. 1989 Jul 28; 58(2):337-47.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.